Skip to main content

Advertisement

ADVERTISEMENT

News

EscharEx - MediWound 

https://clinicaltrials.gov/study/NCT06568627

A 216-patient RCT will evaluate the efficacy and safety of ExcharEX in the debridement of VLUs with the primary outcome of complete debridement at 2 weeks and complete wound closure at 12 weeks. Not yet recruiting; with estimated study completion in Oct 2026. clinicaltrials.gov

Advertisement

Advertisement

Advertisement